SCNI Cash From Investing

Annual CFI

-$637.00 K
+$199.00 K+23.80%

December 31, 2023

Summary

Performance

1-Year Change

+23.8%

3-Year Change

+65.49%

5-Year Change

+89.77%

15-Year Change

-132.76%

SCNI Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.92%
SCNI annual cash flow from investing activities is higher than 46.92% of companies in Healthcare sector

High & Low

All-time High

$1.94 M
SCNI annual cash flow from investing activities is currently -132.76% below its historical high of $1.94 million

3-Year Low

-$836.00 K

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SCNI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 15, 2025
SCNI next annual earnings announcement is scheduled for May 15, 2025

OtherSCNIcash flowmetrics:

Annual CFF

$1.09 M
SCNI annual cash flow from financing activities is $1.09 million

Annual CFO

-$9.38 M
SCNI annual cash flow from operations is -$9.38 million

Annual FCF

-$10.02 M
SCNI annual free cash flow is -$10.02 million

Annual CAPEX

-
SCNI annual capital expenditures value is unknown

Quarterly CFI

-$4000.00
+$2000.00+33.33%

September 1, 2024

Summary

Performance

3-Month Change

+33.33%

1-Year Change

-100%

3-Year Change

+98.52%

5-Year Change

+98.52%

SCNI Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.8%
SCNI quarterly cash flow from investing activities is higher than 53.8% of companies in Healthcare sector

High & Low

All-time High

$1.58 M
SCNI quarterly cash flow from investing activities is currently -100.25% below its historical high of $1.58 million

3-Year Low

-$521.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
SCNI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 15, 2025
SCNI next earnings announcement is scheduled for May 15, 2025

OtherSCNIcash flowmetrics:

Quarterly CFF

$8000.00
SCNI quarterly cash flow from financing activities is $8000.00

Quarterly CFO

-$2.04 M
SCNI quarterly cash flow from operations is -$2.04 million

Quarterly FCF

-$2.04 M
SCNI quarterly free cash flow is -$2.04 million

Quarterly CAPEX

$4000.00
SCNI quarterly capital expenditures is $4000.00

TTM CFI

-$246.00 K
+$16.00 K+6.11%

September 1, 2024

Summary

Performance

3-Month Change

+6.11%

1-Year Change

+61.14%

3-Year Change

+70.57%

5-Year Change

+70.57%

SCNI TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.15%
SCNI TTM cash flow from investing activities is higher than 52.15% of companies in Healthcare sector

High & Low

All-time High

$3.68 M
SCNI TTM cash flow from investing activities is currently -106.68% below its historical high of $3.68 million

3-Year Low

-$836.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
SCNI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 15, 2025
SCNI next earnings announcement is scheduled for May 15, 2025

OtherSCNIcash flowmetrics:

TTM CFF

$1.44 M
SCNI TTM cash flow from financing activities is $1.44 million

TTM CFO

-$6.48 M
SCNI TTM cash flow from operations is -$6.48 million

TTM FCF

-$6.73 M
SCNI TTM free cash flow is -$6.73 million

TTM CAPEX

$10.00 K
SCNI TTM capital expenditures is $10.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SCNI Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+23.8%-100.0%+61.1%
3 y3 years+65.5%+98.5%+70.6%
5 y5 years+89.8%+98.5%+70.6%

SCNI Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-358.3%+23.8%-111.4%+99.2%at high+70.6%
5 y5-year-358.3%+69.4%-111.4%+99.2%at high+70.6%
alltimeall time-132.8%+89.8%-100.3%+99.9%-106.7%+96.1%

Scinai Immunotherapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4000.00(-33.3%)
-$246.00 K(-6.1%)
Jun 2024
-
-$6000.00(+200.0%)
-$262.00 K(-58.6%)
Mar 2024
-
-$2000.00(-99.1%)
-$633.00 K(-0.6%)
Dec 2023
-$637.00 K(-23.8%)
-$234.00 K(+1070.0%)
-$637.00 K(-5.3%)
Sep 2023
-
-$20.00 K(-94.7%)
-$673.00 K(-8.2%)
Jun 2023
-
-$377.00 K(+6183.3%)
-$733.00 K(+128.3%)
Mar 2023
-
-$6000.00(-97.8%)
-$321.00 K(-61.6%)
Dec 2022
-$836.00 K(+501.4%)
-$270.00 K(+237.5%)
-$836.00 K(+47.7%)
Sep 2022
-
-$80.00 K(-328.6%)
-$566.00 K(+16.5%)
Jun 2022
-
$35.00 K(-106.7%)
-$486.00 K(-6.7%)
Mar 2022
-
-$521.00 K(+100.2%)
-$521.00 K(-85.6%)
Dec 2021
-$139.00 K(-92.5%)
-
-
Dec 2020
-$1.85 M(-11.2%)
-
-
Dec 2019
-$2.08 M(-66.6%)
-
-
Jun 2019
-
-$260.30 K(-70.2%)
-$3.62 M(-28.5%)
Mar 2019
-
-$872.10 K(+8.4%)
-$5.06 M(-18.8%)
Dec 2018
-$6.23 M
-$804.50 K(-52.1%)
-$6.23 M(-2.2%)
Sep 2018
-
-$1.68 M(-1.3%)
-$6.36 M(+76.1%)
Jun 2018
-
-$1.70 M(-16.7%)
-$3.61 M(+986.7%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$2.04 M(+117.0%)
-$332.60 K(-117.1%)
Dec 2017
$1.94 M(-195.7%)
-$941.40 K(-187.9%)
$1.94 M(-47.2%)
Sep 2017
-
$1.07 M(-32.2%)
$3.68 M(+30.4%)
Jun 2017
-
$1.58 M(+575.6%)
$2.82 M(-257.5%)
Mar 2017
-
$234.00 K(-70.5%)
-$1.79 M(-11.8%)
Dec 2016
-$2.03 M(>+9900.0%)
$794.30 K(+272.0%)
-$2.03 M(-26.0%)
Sep 2016
-
$213.50 K(-107.0%)
-$2.75 M(-9.7%)
Jun 2016
-
-$3.03 M(>+9900.0%)
-$3.04 M(>+9900.0%)
Mar 2016
-
-$4800.00(-106.1%)
-$15.80 K(+43.6%)
Dec 2015
-$11.00 K(-76.2%)
$79.10 K(-198.9%)
-$11.00 K(-87.5%)
Sep 2015
-
-$80.00 K(+692.1%)
-$87.80 K(+1525.9%)
Jun 2015
-
-$10.10 K(<-9900.0%)
-$5400.00(-258.8%)
Mar 2015
-
$0.00(-100.0%)
$3400.00(-107.3%)
Dec 2014
-$46.20 K(-107.9%)
$2300.00(-4.2%)
-$46.30 K(-4.7%)
Sep 2014
-
$2400.00(-284.6%)
-$48.60 K(-4.7%)
Jun 2014
-
-$1300.00(-97.4%)
-$51.00 K(+2.6%)
Mar 2014
-
-$49.70 K
-$49.70 K
Dec 2013
$581.20 K(-618.0%)
-
-
Dec 2012
-$112.20 K(-84.6%)
-
-
Dec 2011
-$730.20 K
-
-

FAQ

  • What is Scinai Immunotherapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics annual CFI year-on-year change?
  • What is Scinai Immunotherapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics quarterly CFI year-on-year change?
  • What is Scinai Immunotherapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics TTM CFI year-on-year change?

What is Scinai Immunotherapeutics annual cash flow from investing activities?

The current annual CFI of SCNI is -$637.00 K

What is the all time high annual CFI for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high annual cash flow from investing activities is $1.94 M

What is Scinai Immunotherapeutics annual CFI year-on-year change?

Over the past year, SCNI annual cash flow from investing activities has changed by +$199.00 K (+23.80%)

What is Scinai Immunotherapeutics quarterly cash flow from investing activities?

The current quarterly CFI of SCNI is -$4000.00

What is the all time high quarterly CFI for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high quarterly cash flow from investing activities is $1.58 M

What is Scinai Immunotherapeutics quarterly CFI year-on-year change?

Over the past year, SCNI quarterly cash flow from investing activities has changed by -$2000.00 (-100.00%)

What is Scinai Immunotherapeutics TTM cash flow from investing activities?

The current TTM CFI of SCNI is -$246.00 K

What is the all time high TTM CFI for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high TTM cash flow from investing activities is $3.68 M

What is Scinai Immunotherapeutics TTM CFI year-on-year change?

Over the past year, SCNI TTM cash flow from investing activities has changed by +$387.00 K (+61.14%)